Details for New Drug Application (NDA): 021929
✉ Email this page to a colleague
The generic ingredient in SYMBICORT is budesonide; formoterol fumarate. There are twenty-two drug master file entries for this compound. Additional details are available on the budesonide; formoterol fumarate profile page.
Summary for 021929
Tradename: | SYMBICORT |
Applicant: | Astrazeneca |
Ingredient: | budesonide; formoterol fumarate dihydrate |
Patents: | 5 |
Pharmacology for NDA: 021929
Mechanism of Action | Adrenergic beta2-Agonists Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 021929
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929 | NDA | AstraZeneca Pharmaceuticals LP | 0186-0370 | 0186-0370-20 | 1 POUCH in 1 CARTON (0186-0370-20) / 1 CANISTER in 1 POUCH / 120 AEROSOL in 1 CANISTER |
SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929 | NDA | AstraZeneca Pharmaceuticals LP | 0186-0370 | 0186-0370-28 | 1 POUCH in 1 CARTON (0186-0370-28) / 1 CANISTER in 1 POUCH / 60 AEROSOL in 1 CANISTER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.08MG/INH;0.0045MG/INH | ||||
Approval Date: | Jul 21, 2006 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Subscribe | Patent Expiration: | Oct 10, 2026 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | ⤷ Subscribe | Patent Expiration: | Sep 26, 2027 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | ⤷ Subscribe | Patent Expiration: | Apr 16, 2029 | Product Flag? | Substance Flag? | Delist Request? | Y |
Expired US Patents for NDA 021929
Complete Access Available with Subscription